Linezolid is Associated with Improved Early Outcomes of Childhood Tuberculous Meningitis
Authors:
- Jie LuJLJie Lu
- Jinrong LiuJLJinrong Liu
- Yuhong ZhaoYZYuhong Zhao
- Xin NiXNXin Ni
- Shunying ZhaoSZShunying Zhao
- 1 June 2016
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 35 (6) , 607-610
Abstract
Linezolid serves as an important component for the treatment of drug-resistant tuberculosis although there is little published data about linezolid use in children, especially in childhood tuberculous meningitis (TBM). In this study, we retrospectively reviewed records of childhood TBM patients who started treatment between January 2012 and August 2014. A total of 86 childhood TBM patients younger than 15 years old were enrolled. Out of 86 children, 36 (41.9%) received the regimen containing linezolid. Thirty-two (88.9%) of 36 linezolid-treated cases had favorable outcomes, and 35 (70.0%) cases were successfully treated in the control group. The frequency of favorable outcome of linezolid group was significantly higher than that of control group (P = 0.037). In addition, compared with cases with fever clearance time of 4 weeks (P = 0.000) than linezolid group. Furthermore, there was no significant difference in the frequency of adverse events between the two regimens (P = 0.896). In addition, the patients with adverse events were more likely to have treatment failure, the P value of which was 0.008. Our data demonstrate that linezolid improves early outcome of childhood TBM. The low frequency of linezolid-associated adverse effects highlights the promising prospects of its use for treatment of childhood TBM.Keywords
This publication has 25 references indexed in Scilit:
- Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in ChinaInternational Journal of Antimicrobial Agents, 2014
- Tuberculous meningitis: more questions, still too few answersThe Lancet Neurology, 2013
- Advances in the diagnosis and treatment of tuberculous meningitisCurrent Opinion in Neurology, 2013
- Diagnosing tuberculous meningitis – have we made any progress?Tropical Medicine & International Health, 2013
- Diagnosis and therapy of tuberculous meningitis in childrenTuberculosis, 2012
- Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and AdultsNew England Journal of Medicine, 2004
- In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculous DrugsAntimicrobial Agents and Chemotherapy, 2003
- Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine ModelAntimicrobial Agents and Chemotherapy, 1999
- Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998Thorax, 1998